Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

Date
2017Author
Ensina, L. F. [UNIFESP]
Cusato-Ensina, A. P.
Camelo-Nunes, I. C. [UNIFESP]
Sole, D. [UNIFESP]
Type
EditorialISSN
1018-9068Is part of
Journal Of Investigational Allergology And Clinical ImmunologyDOI
10.18176/jiaci.0179Metadata
Show full item recordCitation
Journal Of Investigational Allergology And Clinical Immunology. Barcelona, v. 27, n. 5, p. 326-327, 2017.Keywords
UrticariaOmalizumab
Angioedema
Therapeutics
Collections
- EPM - Outras produções [3595]